you are here: Home News Biological E

Biological E

Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses
Biological E gets DCGI nod to market Pneumococcal Conjugate Vaccine in India
Biological-E developing Omicron specific vaccine, contemplating it to be used as bivalent jab: Mahima Datla, CEO
SEC recommends Biological E's vaccine against S pneumonia for infants
31 companies express interest in developing Monkeypox vaccines, kits; Serum, Biological E in race
From August 12, option of Corbevax as booster doses for all jabbed with Covaxin, Covishield earlier
Centre plans second-generation COVID vaccines to tackle mutating variants
Corbevax as booster dose after Covaxin, Covishield? Top panel on immunisation to discuss possibility
Top virologists weigh in for Corbevax booster after primary vaccination with Covishield, Covaxin
Biological E. cuts price of its COVID-19 vaccine to Rs 250 per dose
Exclusive: Supplied nearly 100 million doses to Govt; committed to meeting growing demand for Corbevax: Biological E’s COO
COVID-19 vaccines for 5-11-year-olds may be limited to private hospitals
Biological E to get mRNA technology from WHO to produce COVID-19 vaccines
Huge response to COVID-19 shots for 12-14 age group; private hospitals keep away
COVID-19 Vaccine | Govt to procure Corbevax at Rs 290 for two doses, private hospitals at Rs 800
In Depth | As demand for COVID-19 vaccine dips in India, government and companies look to step up exports
COVID-19 Vaccine | Corbevax gets DCGI nod for emergency use in 12-18 year olds
Biological E seeks EUA for its Corbevax vaccine for 12-18 yrs age group
COVID-19 Vaccine | India to get first supply of Corbevax from February 15: Report
Centre places purchase order for 5 crore doses of Corbevax Covid vaccine each costing Rs 145 sans tax
About 1 crore doses of SII's Covovax cleared by govt lab for public use, testing of Bio E's Corbevax to begin
Biological E aims to produce 100 million doses/month of Corbevax from February 2022
DFC to finance $50 million to Biological E to expand COVID-19 vaccine manufacturing capacity
Mansukh Mandaviya holds meeting with Biological-E MD on progress of COVID vaccine
COVID-19 Vaccines | Biological E to begin producing 75-80 million doses of vaccine candidate from August 2021

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Biological E

Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses

Biological E gets DCGI nod to market Pneumococcal Conjugate Vaccine in India

Biological-E developing Omicron specific vaccine, contemplating it to be used as bivalent jab: Mahima Datla, CEO

SEC recommends Biological E's vaccine against S pneumonia for infants

31 companies express interest in developing Monkeypox vaccines, kits; Serum, Biological E in race

From August 12, option of Corbevax as booster doses for all jabbed with Covaxin, Covishield earlier

Centre plans second-generation COVID vaccines to tackle mutating variants

Corbevax as booster dose after Covaxin, Covishield? Top panel on immunisation to discuss possibility

Top virologists weigh in for Corbevax booster after primary vaccination with Covishield, Covaxin

Biological E. cuts price of its COVID-19 vaccine to Rs 250 per dose

Exclusive: Supplied nearly 100 million doses to Govt; committed to meeting growing demand for Corbevax: Biological E’s COO

COVID-19 vaccines for 5-11-year-olds may be limited to private hospitals

Biological E to get mRNA technology from WHO to produce COVID-19 vaccines

Huge response to COVID-19 shots for 12-14 age group; private hospitals keep away

COVID-19 Vaccine | Govt to procure Corbevax at Rs 290 for two doses, private hospitals at Rs 800

In Depth | As demand for COVID-19 vaccine dips in India, government and companies look to step up exports

COVID-19 Vaccine | Corbevax gets DCGI nod for emergency use in 12-18 year olds

Biological E seeks EUA for its Corbevax vaccine for 12-18 yrs age group

COVID-19 Vaccine | India to get first supply of Corbevax from February 15: Report

Centre places purchase order for 5 crore doses of Corbevax Covid vaccine each costing Rs 145 sans tax

About 1 crore doses of SII's Covovax cleared by govt lab for public use, testing of Bio E's Corbevax to begin

Biological E aims to produce 100 million doses/month of Corbevax from February 2022

DFC to finance $50 million to Biological E to expand COVID-19 vaccine manufacturing capacity

Mansukh Mandaviya holds meeting with Biological-E MD on progress of COVID vaccine

COVID-19 Vaccines | Biological E to begin producing 75-80 million doses of vaccine candidate from August 2021